Most Americans, who have private insurance, likely will not benefit immediately from efforts to lower prescription drug ...

In the latest close session, Pfizer (PFE) was up +1.12% at $25.18. The stock outpaced the S&P 500's daily gain of 0.19%. Meanwhile, the Dow experienced a rise of 0.66%, and the technology-dominated ...

Pfizer enters 2026 facing earnings pressure from COVID revenue collapse and acquisition-related dilution. Click here to read ...

Pfizer Inc. (NYSE:PFE) ranks among the best stocks under $25 to buy now. Citing the company’s cautious 2026 outlook, BMO ...

Here, BioSpace looks back at the biggest acquisition deals of 2025. Target: Intra-Cellular Therapies Acquisition date: ...

Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic ...

Jim Cramer has a reputation for getting market calls wrong, but what if you put $1,000 in Inverse Cramer at the start of 2025 ...

How $2,670 split across three durable high-yield stocks can generate $300 in annual dividends without risky payouts.

Given the stock's less-than favorable performance during the last few years as it emerged from its pandemic growth days and ...

BIDMC study shows even a single binge drinking episode can damage the gut lining, trigger inflammation, and cause “leaky gut” ...

Pfizer Inc. (NYSE:PFE) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 16, Pfizer Inc. (NYSE ...

These high-octane dividend stocks -- sporting an average yield of 11.25% -- have the catalysts needed to sustainably pad the ...